INTERLEUKIN GENETICS
Interleukin Genetics, Inc. is a genetics-focused personalized health company that develops genetic tests for sale to the emerging personalized health market. Their vision is to build a leading personalized health and wellness company. They believe that the science of applied genetics can empower individuals to personalize their health and provide valuable information to assist in drug development. They currently have two primary focus areas to their business. The first is personalized health, wh... ich is primarily focused on providing genetic test products to customers. These products are distributed via sales partners and their own sales channels, with the goal of providing guidance for the individual interested in improving their health and wellness. The second is a research and development effort focused on developing genetic tests linked to a partner’s products for marketing and sales into medical and dental channels. Both areas contribute toward their overall mission of providing products that can help individuals improve and maintain their health through preventive measures.
INTERLEUKIN GENETICS
Industry:
Biotechnology Genetics Health Care Medical
Founded:
1997-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.ilgenetics.com
Total Employee:
11+
Status:
Closed
Contact:
(781) 398-0700
Email Addresses:
[email protected]
Total Funding:
64.54 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Nginx Google Adsense AdBlock Acceptable Ads Google Adsense For Domains Liquid Web ParkLogic DNS
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2006-08-17 | Alan James Group | Alan James Group acquired by Interleukin Genetics | N/A |
Investors List
Bay City Capital
Bay City Capital investment in Post-IPO Equity - Interleukin Genetics
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Interleukin Genetics
Horizon Technology Finance
Horizon Technology Finance investment in Post-IPO Debt - Interleukin Genetics
Bay City Capital
Bay City Capital investment in Post-IPO Equity - Interleukin Genetics
Delta Dental of Oklahoma
Delta Dental of Oklahoma investment in Post-IPO Equity - Interleukin Genetics
Alticor Corporate Enterprises
Alticor Corporate Enterprises investment in Post-IPO Equity - Interleukin Genetics
